The biannual meeting of the ESDPPP (European Society of Developmental Perinatal and Pediatric Pharmacology) was held in Belgrade, Serbia from June 23rd-26th 2015. This event provided a perfect platform to share data and results of the ongoing research of our consortium with experts on pediatric pharmacology from all over the world. Presentations (n=11) covered both oral (o) as well as poster (p) presentations. The list is hereunder provided chronologically.
- SAFE-PEDRUG: a new strategy for paediatric drug research. P De Bruyne (p)
- Prospective validation of a model-based dosing regimen for amikacin in neonates: feasible and relevant. A Smits (p)
- The role of the pediatric pharmacologist in the rational use of medicines in neonatal medicine. K Allegaert (o)
- Unintentional overdosing of intravenous paracetamol in neonates: where is the toxicity ? K Allegaert (p)
- How safe is on-label drug use in paediatrics: the case of first generation H1-antihistamines ? P De Bruyne (p)
- Use of fluoroquinolones in hospitalized children, preliminary report of a chart review in a Belgian university children’s hospital. K Meesters (p)
- Dose-finding study and pharmacodynamics assessment of propofol for (semi)-elective intubation in neonates. A Smits (o)
- To what extent does the vancomycin assay contributes to the variability in vancomycin concentration estimates in neonates. J Samardzic (o)
- Augmented renal clearance implies a need for increased amoxicillin-clavulanate dosing in critically ill children. P de Cock (o)
- Possible confounders in the reported association between autism spectrum disorder (ASD) and exposure to selective serotonin reuptake inhibitors (SSRIs). P De Bruyne (o)
- Novel treatment modalities in neonates. The value of serendipity. K Allegaert (o)
The related abstracts can be found here. More information can be retrieved through the e-mail link (firstname.lastname@example.org). The next ESDPPP conference will be held in Belgium (2017), and will provide another opportunity for valorization and information diffusion, including to Belgian colleagues.